Back to results
US 2014/0155329 A1Published application
Long-Acting Peptide Analogs
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsSheau Yu Hsu, Chia Lin Chang
Life of this patent
Estimating the term…
Abstract
Long-acting agonistic analogs for CLR/RAMP receptors are provided that have an extended half-live in vivo.
Claims10
A biologically active intermedin or adrenomedullin peptide having a serum half-life of greater than 1.5 hours.
Dependencies are inferred from the claim text.